Automation will Represent the Next Big Step for Biobanks, Says Frost & Sullivan

News   Jan 07, 2013

 
Automation will Represent the Next Big Step for Biobanks, Says Frost & Sullivan
 
 
 

RELATED ARTICLES

Compliant-Ready LIMS Launched by LabVantage

News

LabVantage launches LIMS software that is the first GxP-compliant solution for data integrity and auditing, to help drug manufacturers conform to the FDA draft guidance on “Data Integrity and Compliance with CGMP.”

READ MORE

BC Platforms Announces Collaborations in Multiple Sclerosis Research

News

Company's technology and research platforms used to better understand genetic basis of MS.

READ MORE

Pathway in Neurons may Contribute to Neurodegenerative Disease

News

Pathway has received attention as potential drug target.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science Informatics & Automation

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE